C12N 2710/24063
By chemical treatment
Official title: by chemical treatment
C12N2710/24063 (By chemical treatment) appears on 4 US grants and 5 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 5
- Assignees
- 3
- Inventors
- 7
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 1 | 0 |
| 2013 | 0 | 1 |
| 2014 | 1 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for inducing an enhanced immune response using poxvirus vectors2 Jun 2026US 12,644,125 B2Bavarian Nordic A/S
- Inactivating pathogens with oxidizing agents for vaccine production4 Dec 2018US 10,143,740 B2Oregon Health & Science University
- Inactivating pathogens with oxidizing agents for vaccine production6 May 2014US 8,716,000 B2Oregon Health & Science University
- Inactivating pathogens with oxidizing agents for vaccine production28 Feb 2012US 8,124,397 B2Oregon Health & Science University
- Compositions and Methods for Inducing an Enhanced Immune Response Using Poxvirus Vectors15 Oct 2020US 2020/0325477 A1Bavarian Nordic A/S
- Compositions and methods for inducing an enhanced immune response using poxvirus vectors29 Dec 2016US 2016/0376596 A1Bavarian Nordic A/S
- Inactivating pathogens with oxidizing agents for vaccine production28 Aug 2014US 2014/0242115 A1Oregon Health & Science University
- Inactivating pathogens with oxidizing agents for vaccine production3 Jan 2013US 2013/0004525 A1Oregon Health & Science University
- Inactivating pathogens with hydrogen peroxide for vaccine production8 Feb 2007US 2007/0031451 A1Oregon Health & Science University
Most cited
By later US patents